{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:33:44Z","timestamp":1793158424328,"version":"4.5.0"},"reference-count":43,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"DOI":"10.1590\/s1678-9946202163011","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T12:39:09Z","timestamp":1611923949000},"source":"Crossref","is-referenced-by-count":26,"title":["Circumsporozoite Surface Protein-based malaria vaccines: a review"],"prefix":"10.1590","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3348-5409","authenticated-orcid":false,"given":"Maria Edilene Martins de","family":"Almeida","sequence":"first","affiliation":[{"name":"Fiocruz Amaz\u00f4nia,  Brazil; Fiocruz,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriella Santos de","family":"Vasconcelos","sequence":"additional","affiliation":[{"name":"Fiocruz Amaz\u00f4nia,  Brazil; Centro Universit\u00e1rio Fametro,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3125-580X","authenticated-orcid":false,"given":"Andr\u00e9a Monteiro","family":"Tarrag\u00f4","sequence":"additional","affiliation":[{"name":"Universidade Federal do Amazonas,  Brazil; Funda\u00e7\u00e3o Hospitalar de Hematologia e Hemoterapia do Amazonas,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Andr\u00e9 Morais","family":"Mari\u00faba","sequence":"additional","affiliation":[{"name":"Fiocruz Amaz\u00f4nia,  Brazil; Fiocruz,  Brazil; Universidade Federal do Amazonas,  Brazil; Universidade Federal do Amazonas,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2021]]},"reference":[{"key":"ref1","series-title":"World malaria report 2019","year":"2019"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1586\/14760584.6.5.723","article-title":"GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives","volume":"6","author":"Gar\u00e7on N","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM199701093360202","article-title":"A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group","volume":"336","author":"Stoute JA","year":"1997","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa0807381","article-title":"Efficacy of RTS,S\/AS01E vaccine against malaria in children 5 to 17 months of age","volume":"359","author":"Bejon P","year":"2008","journal-title":"N Engl J Med"},{"key":"ref5","series-title":"First malaria vaccine receives positive scientific opinion from EMA: press release 24\/07\/2015"},{"key":"ref6","series-title":"Q&A on the malaria vaccine implementation programme (MVIP): march 2020"},{"key":"ref7","series-title":"First malaria vaccine: a potential new tool for child health and improved malaria control"},{"key":"ref8","article-title":"Efficacy and safety of the RTS,S\/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites","volume":"11","year":"2014","journal-title":"PLoS Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14760584.2016.1213632","article-title":"Adjuvant system AS01: helping to overcome the challenges of modern vaccines","volume":"16","author":"Didierlaurent AM","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0264-410X(96)00293-9","article-title":"Induction of cross-reactive cytotoxic T-lymphocyte responses specific for HIV-1 gp120 using saponin adjuvant (QS-21) supplemented subunit vaccine formulations","volume":"15","author":"Newman MJ","year":"1997","journal-title":"Vaccine"},{"key":"ref11","first-page":"1","article-title":"Proc\u00e9d\u00e9s pour accro\u00eetre la production de antitoxines","volume":"40","author":"Ramon G","year":"1926","journal-title":"Ann Inst Pasteur"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/path.1700340214","article-title":"Rate of disappearance of diphtheria toxoid injected into rabbits and guinea-pigs: toxoid precipitated with alum","volume":"34","author":"Glenny AT","year":"1931","journal-title":"J Pathol Bacteriol"},{"key":"ref13","series-title":"(How) do aluminium adjuvants work\/Immunol Lett","first-page":"10","volume":"102","author":"Brewer JM","year":"2006"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1126\/science.102.2643.200","article-title":"Immunization against malaria: vaccination of ducks with killed parasites incorporated with adjuvants","volume":"102","author":"Freund J","year":"1945","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/216160a0","article-title":"Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei","volume":"216","author":"Nussenzweig RS","year":"1967","journal-title":"Nature"},{"key":"ref16","first-page":"165","article-title":"Preliminary studies on vaccination of Rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites","volume":"57","author":"Gwadz RW","year":"1979","journal-title":"Bull World Health Organ"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00000441-197309000-00002","article-title":"Immunization of man against sporozite-induced falciparum malaria","volume":"266","author":"Clyde DF","year":"1973","journal-title":"Am J Med Sci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0014-4894(87)90182-2","article-title":"Plasmodium falciparum: elicitation by peptides and recombinant circumsporozoite proteins of circulating mouse antibodies inhibiting sporozoite invasion of hepatoma cells","volume":"63","author":"Hollingdale MR","year":"1987","journal-title":"Exp Parasitol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1126\/science.2480642","article-title":"Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer","volume":"246","author":"Nardin EH","year":"1989","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1074\/jbc.M106862200","article-title":"Binding and invasion of liver cells by Plasmodium falciparum sporozoites: essential involvement of the amino terminus of circumsporozoite protein","volume":"277","author":"Rathore D","year":"2002","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1126\/science.2988125","article-title":"Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine","volume":"228","author":"Young JF","year":"1985","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1084\/jem.20040989","article-title":"The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion","volume":"201","author":"Coppi A","year":"2005","journal-title":"J Exp Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1074-7613(00)80513-0","article-title":"Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles","volume":"7","author":"Doolan DL","year":"1997","journal-title":"Immunity"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/infdis\/171.6.1576","article-title":"Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine","volume":"171","author":"Gordon DM","year":"1995","journal-title":"J Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"7817","DOI":"10.1073\/pnas.1205737109","article-title":"Unexpected fold in the circumsporozoite protein target of malaria vaccines","volume":"109","author":"Doud MB","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1016\/j.vaccine.2015.09.061","article-title":"RTS\u2019S: toward a first landmark on the malaria vaccine technology roadmap","volume":"33","author":"Kaslow DC","year":"2015","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/0022-3859.173187","article-title":"The clinical development process for a novel preventive vaccine: an overview","volume":"62","author":"Singh K","year":"2016","journal-title":"J Postgrad Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/328257a0","article-title":"Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites","volume":"328","author":"Herrington DA","year":"1987","journal-title":"Nature"},{"key":"ref29","first-page":"1065","article-title":"Hepatitis B surface antigen as a carrier matrix for the repetitive epitope of the circumsporozoite protein of Plasmodium falciparum","volume":"6","author":"Rutgers T","year":"1988","journal-title":"Bio\/Technology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.1991.45.533","article-title":"Phase I clinical trial of a recombinant malaria vaccine consisting of the circumsporozoite repeat region of Plasmodium falciparum coupled to hepatitis B surface antigen","volume":"45","author":"Vreden SG","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/515657","article-title":"Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine","volume":"178","author":"Stoute JA","year":"1998","journal-title":"J Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/318534","article-title":"Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria","volume":"183","author":"Kester KE","year":"2001","journal-title":"J Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(01)06957-4","article-title":"Efficacy of RTS,S\/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial","volume":"358","author":"Bojang KA","year":"2001","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1056\/NEJMoa0807773","article-title":"Safety and immunogenicity of RTS,S\/AS02D malaria vaccine in infants","volume":"359","author":"Abdulla S","year":"2008","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013838","article-title":"Safety, immunogenicity and duration of protection of the RTS,S\/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I\/IIb trial","volume":"5","author":"Aide P","year":"2010","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/imr.12802","article-title":"Complement in malaria immunity and vaccines","volume":"293","author":"Kurtovic L","year":"2020","journal-title":"Immunol Rev"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.1016\/j.vaccine.2006.06.035","article-title":"Cutaneous delayed-type hypersensitivity (DTH) in a multi-formulation comparator trial of the anti-falciparum malaria vaccine candidate RTS,S in Rhesus macaques","volume":"24","author":"Stewart VA","year":"2006","journal-title":"Vaccine"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"ref39","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-019-1378-6","article-title":"RTS,S\/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study","volume":"17","author":"Doba\u00f1o C","year":"2019","journal-title":"BMC Med"},{"key":"ref40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043430","article-title":"Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine","volume":"7","author":"Zeeshan M","year":"2012","journal-title":"PLoS One"},{"key":"ref41","article-title":"Genetic polymorphism and natural selection of circumsporozoite surface protein in Plasmodium falciparum field isolates from Myanmar","volume":"17","author":"L\u00ea HG","year":"2018","journal-title":"Malar J"},{"key":"ref42","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-019-2970-0","article-title":"Genetic polymorphism of the N-terminal region in circumsporozoite surface protein of Plasmodium falciparum field isolates from Sudan","volume":"18","author":"Mohamed NS","year":"2019","journal-title":"Malar J"},{"key":"ref43","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-4467-4","article-title":"Mass campaigns combining antimalarial drugs and anti-infective vaccines as seasonal interventions for malaria control, elimination and prevention of resurgence: a modelling study","volume":"19","author":"Camponovo F","year":"2019","journal-title":"BMC Infect Dis"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rimtsp\/v63\/1678-9946-rimtsp-63-S1678-9946202163011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T06:39:08Z","timestamp":1613111948000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652021000100400&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":43,"alternative-id":["S0036-46652021000100400"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946202163011","relation":{},"ISSN":["1678-9946"],"issn-type":[{"value":"1678-9946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"e11"}}